This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Langlois, M.-A.
Right arrow Articles by Neuberger, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Langlois, M.-A.
Right arrow Articles by Neuberger, M. S.

 Previous Article  |  Next Article 

Journal of Virology, May 2008, p. 4660-4664, Vol. 82, No. 9
0022-538X/08/$08.00+0     doi:10.1128/JVI.02469-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Human APOBEC3G Can Restrict Retroviral Infection in Avian Cells and Acts Independently of both UNG and SMUG1{triangledown}

Marc-André Langlois* and Michael S. Neuberger

Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 0QH, United Kingdom

Received 16 November 2007/ Accepted 6 February 2008

APOBEC3 proteins are mammal-specific cytidine deaminases that can restrict retroviral infection. The exact mechanism of the restriction remains unresolved, but one model envisions that uracilated retroviral cDNA, generated by cytidine deamination, is the target of cellular glycosylases. While restriction is unaffected by UNG deficiency, it has been suggested that the SMUG1 glycosylase might provide a backup. We found that retroviral restriction can be achieved by introducing human APOBEC3G into chicken cells (consistent with the components necessary for APOBEC3-mediated restriction predating mammalian evolution) and used this assay to show that APOBEC3G-mediated restriction can occur in cells deficient in both UNG and SMUG1.

* Corresponding author. Mailing address: Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, United Kingdom. Phone: (44) 1223 402299. Fax: (44) 1223 412178. E-mail: mal{at}mrc-lmb.cam.ac.uk

{triangledown} Published ahead of print on 13 February 2008.

Journal of Virology, May 2008, p. 4660-4664, Vol. 82, No. 9
0022-538X/08/$08.00+0     doi:10.1128/JVI.02469-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Henriet, S., Mercenne, G., Bernacchi, S., Paillart, J.-C., Marquet, R. (2009). Tumultuous Relationship between the Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) and the Human APOBEC-3G and APOBEC-3F Restriction Factors. Microbiol. Mol. Biol. Rev. 73: 211-232 [Abstract] [Full Text]  
  • Shivarov, V., Shinkura, R., Doi, T., Begum, N. A, Nagaoka, H., Okazaki, I.-M., Ito, S., Nonaka, T., Kinoshita, K., Honjo, T. (2009). Molecular mechanism for generation of antibody memory. Phil Trans R Soc B 364: 569-575 [Abstract] [Full Text]  
  • Malim, M. H (2009). APOBEC proteins and intrinsic resistance to HIV-1 infection. Phil Trans R Soc B 364: 675-687 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»